Last updated on March 2019

DOM-INNATE: Study of SGX942 for the Treatment of Oral Mucositis in Patients With Concomitant Chemoradiation Therapy for Head and Neck Cancer


Brief description of study

To assess the efficacy of SGX942 compared to placebo in decreasing the duration of severe oral mucositis in patients receiving chemoradiation treatment for the treatment of head and neck cancer

Clinical Study Identifier: NCT03237325

Contact Investigators or Research Sites near you

Start Over

Willis Knighton Cancer Center

Shreveport, LA United States
  Connect »

Broward Health Medical Center

Fort Lauderdale, FL United States
  Connect »

Tulane University

New Orleans, LA United States
  Connect »

Karmanos Cancer Institute

Detroit, MI United States
  Connect »

University of Rochester

Rochester, NY United States
  Connect »

Charleston Cancer Center

Charleston, SC United States
  Connect »

Lakes Research

Miami Lakes, FL United States
  Connect »

Hackensack Meridian Health

Neptune, NJ United States
  Connect »

CHI Health St. Francis

Grand Island, NE United States
  Connect »

Mercy Clinic Oncology and Hematology

Oklahoma City, OK United States
  Connect »

Marin Cancer Care

Greenbrae, CA United States
  Connect »

Loma Linda University Health

Loma Linda, CA United States
  Connect »

Carle Cancer Center

Urbana, IL United States
  Connect »

Minnesota Oncology

Saint Louis Park, MN United States
  Connect »

The Christ Hospital

Cincinnati, OH United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.